ArticleBritish journal of cancer2007

Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.

C Barone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.